期刊文献+

猪骨髓间充质干细胞成骨分化后SLA的表达及免疫原性研究 被引量:3

Expressions of swine lymphocyte antigen on osteogenic cells differentiated from mesenchymal stem cells and its immunogenicity
下载PDF
导出
摘要 目的研究猪骨髓间充质干细胞成骨分化后(osteogenic cells differentiatedfrommesenchymal stemcell,DOC)在IFN-γ刺激下猪白细胞抗原(swine lymphocyte antigen,SLA)基因的表达变化及对外周单个核细胞(PBMC)增殖的影响。从而了解其免疫原性。方法以未分化的MSC为对照,采用RT-PCR技术分别检测DOC、未分化的MSC、MSC+IFN-γ组、DOC+IFN-γ的SLA基因表达情况,采用单向混合淋巴反应观察各组细胞对植物血凝素(PHA)刺激PBMC的每分钟脉冲值(CPM)变化。结果DOC组、MSC+IFN-γ组、DOC+IFN-γ组SLA-I(P1,P14)表达上调(P<0.05),SLA-Ⅱ(DRA、DRB、DQA、DQB)表达明显上调(P<0.01)。并能抑制PHA刺激的PBMC增殖反应。结论在体外实验中,DOC在IFN-γ刺激下仍具有低免疫原性,且具有免疫调节作用。 Objective To investigate the gene expression variation of swine lymphocyte antigen (SLA) on esteogenie cells differentiated from mesenchymal stem cells (DOC) under stimulation of IFN-γ, and its effects on proliferation of peripheral blood mononuclear cell (PBMC), for explaining the immunogenicity of SLA. Methods The SLA gene expression variation of DOC treated with or without IFN-γ was detected by RT-PCR, with undiferentiated MSC as control group. CPM variation of PBMC + phytohemagglutinin (PHA) was explored by one-aymixed lymphocyte culture (MLC) after adding DOC treated with or without IFN-γ. Results Porcine SLA-Ⅰ(P1, P14)expressions were up-regulated in DOC, MSC + IFN-γ, and DOC + IFN-γ groups (P 〈0.05), while SLA- Ⅱ (DRA, DRB, DQA, and DQB) were up-regulated significantly in these groups ( P 〈 0.01 ). DOC could suppress PBMC proliferation induced by PHA. Conclusion In vitro, whatever DOC treated with IFN-γ or not, DOC still keep low immunogenieity and perform immunogenie function.
出处 《免疫学杂志》 CAS CSCD 北大核心 2007年第3期298-301,305,共5页 Immunological Journal
基金 国家高技术研究发展资助重大攻关课题资助("863"计划 2006-AA205020)
关键词 骨髓间充质干细胞 成骨分化 SLA 免疫原性 Mesenehymal stem cell Osteogenie cells differentiated from mesenehymal stem cells Swine lymphocyte antigen Immunngenicity
  • 相关文献

参考文献9

  • 1Dley JA, Bolton EM, Pedersen RA. Stem cell medicine encounters the immune system [ J ] Nat Rev Immunol, 2002, 2(11): 859-871.
  • 2Simonsen JL, Rosada C, Serakinci N. et al. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells[J]. Nat Biotechnol, 2002, 20 (6): 592- 596.
  • 3Bartholomew A, Sturgeon C, Siatskas Met ol. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo [ J]. Exp Hematol, 2 1302, 30(1):42-48.
  • 4Le Blanc K. Mesenchymal stem cells. Basic science and future clinical use [ J ].Lakartidningen, 2002, 99 ( 12 ) : 1 318-1821.
  • 5Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses [ J ]. Blood, 2005, 105 (4): 1 815- 1 822.
  • 6Maccario R, Podesta M, Moretta A, et al. Interaction of human mesenchymal stem cells with cells involved in alloantigen- specific immune response favors the differentiation of CD4^+ T-cellsubsets expressing a regulatory/suppressive phenotype [J]. Haematologica, 2005, 90 (4): 516-525.
  • 7Niemeyer P, Seckinger A, Simank G, et al. Allogenic transplantation of human mesenchymal stem cells for tissue engineering purposes: an in vitrostudy [ J]. Orthopade, 2004, 33(12): 1 346- 1 353.
  • 8Le Blanc K, Tammik C, Rosendahl K, et al. HLA expression and immunologic properties of differentiated and undiff erentiated mesenchymal stem cells [J]. Exp Hematol, 2003, 31 (10): 890-896.
  • 9Plumas J, Chaperot L, Richard MJ, et ol. Mesenchymal stem cells induce apoptosis of activated T cells [ J ]. Leukemia, 2005, 19 (9): 1597-1604.

同被引文献47

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部